Announcement

Collapse
No announcement yet.

FDA Panel Endorses Booster for All J&J Recipients

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • FDA Panel Endorses Booster for All J&J Recipients

    — Committee advises booster at least 2 months following initial Johnson & Johnson shot

    October 15, 2021
    by Molly Walker

    Despite limited available data, an FDA advisory panel recommended a booster dose of Johnson & Johnson's COVID-19 vaccine for all individuals who received the single-dose vaccine, to be given at least 2 months after the initial dose.

    The FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 19-0 that the booster dose at this interval was safe and effective for individuals ages 18 and up who received the Johnson & Johnson vaccine under emergency use authorization (EUA).

    Committee advises booster at least 2 months following initial Johnson & Johnson shot



  • #2
    bump this

    Comment

    Working...
    X